Technology News and Research

RSS

Intelligent panic disorder treatment by using biofeedback analysis and web technologies

An online treatment system for patients suffering with panic disorder and anxiety problems combine biofeedback therapy with web technologies and allows patients and medical professionals to communicate effectively, according to research published in the International Journal of Business Intelligence and Data Mining.

20 Jan 2010

New pre-clinical data on RXi Pharmaceuticals' proprietary rxRNA compounds presented

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that new pre-clinical data using proprietary rxRNA™ compounds was presented at the Keystone Symposia’s RNA Silencing: Mechanism, Biology and Application held January 14-19 in Keystone, Colorado.

20 Jan 2010

New minimally invasive surgery for lung cancer reduces post-operative pain

Generally, after traditional open-chest surgery for lung cancer, patients may experience a significant amount of pain and spend up to a week in the hospital followed by months recovering.

20 Jan 2010

New heating therapy reduces mastectomies, kills large tumors

A new treatment developed and tested by University of Oklahoma researchers not only killed large breast cancer tumors, but reduced the need for mastectomies by almost 90 percent. The latest results appear in an upcoming issue of the Annals of Surgical Oncology.

20 Jan 2010

Researchers show how gliomas can evade drugs aimed at blocking EGFR

Researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine and Moores UCSD Cancer Center have shown one way in which gliomas, a deadly type of brain tumor, can evade drugs aimed at blocking a key cell signaling protein, epidermal growth factor receptor (EGFR),that is crucial for tumor growth.

20 Jan 2010

Radiology Regional Center initiates participation in SOMO•INSIGHT Clinical Study

U-Systems announced today that Radiology Regional Center has initiated participation in the SOMO•INSIGHT Clinical Study. The first breast center in Southwest Florida to participate, Radiology Regional Center is recruiting participants for the national clinical research study designed to evaluate whether digital mammography in combination with the somo•v™ Automated Breast Ultrasound System (ABUS) from U-Systems is more sensitive to detecting breast lesions when compared to Mammography alone in women with dense breasts.

20 Jan 2010

Ericson Manufacturing supports breast cancer research and community outreach projects

In 2010 Ericson Manufacturing Company will make significant strides in the support of national breast cancer awareness through a new partnership with Susan G. Komen for the Cure®, the world’s largest breast cancer advocacy organization.

20 Jan 2010

Access Pharmaceuticals provides update on its Cobalamin insulin development program

ACCESS PHARMACEUTICALS, INC. provided an update today on its Cobalamin™ oral drug delivery product development programs. The proprietary Cobalamin™ technology utilizes the body's natural vitamin B12 oral uptake mechanism to facilitate oral absorption of pharmaceuticals by a "Trojan horse" mechanism.

20 Jan 2010

GEH, Exelon Generation agree to a landmark deal to deploy GEH’s isotope generation technology

Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to a landmark deal to deploy GEH’s isotope generation technology.

20 Jan 2010

Edwards Lifesciences' German Andersen patent for transcatheter valve technology upheld

Edwards Lifesciences Corporation, the world leader in the science of heart valves, announced today that the Federal Patent Court in Munich, Germany, has upheld the validity of Edwards' German Andersen patent for transcatheter valve technology. Edwards succeeded in having CoreValve's invalidity claims dismissed on all grounds.

20 Jan 2010

Lumigent Technologies closes $3 million round of funding from North Bridge Venture Partners

Lumigent Technologies, Inc., the GRC business apps company, today announced it has capped its success in 2009 by closing a new, $3 million round of funding from North Bridge Venture Partners.

20 Jan 2010

Cook Medical presents latest advancements at ISET 2010 International Symposium on Endovascular Therapy

Signaling its continued commitment to addressing the anatomy of the entire peripheral vasculature and combating disease with targeted diagnostic and interventional devices, Cook Medical is presenting its latest advancements at the ISET 2010 International Symposium on Endovascular Therapy.

20 Jan 2010

St. Louis Children's Hospital installs Siemens' SOMATOM Definition AS CT scanner

Recognized as one of the leading pediatric healthcare centers in the United States, St. Louis Children's Hospital in St. Louis is further enhancing its nationally renowned pediatric care program with the installation of a SOMATOM® Definition AS computed tomography (CT) scanner from Siemens Healthcare. The SOMATOM Definition AS is the world's first adaptive scanner, which intelligently adapts, on the fly, to the patient, for aiding in dose protection, as well as adapting to new dimensions and space.

20 Jan 2010

Dynamic mapping may help in detecting links between diseases and environmental exposures

A team of researchers has developed a dynamic mapping tool to gain a more nuanced view of the links between diseases and environmental exposures. The application of the method is illustrated by a number of examples of associations between environmental exposures and Salmonella infections among people in the US age 65 and over in 2002.

20 Jan 2010

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the “RNA Silencing: Mechanism, Biology, and Application” Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam’s therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington’s disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.

20 Jan 2010

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) announced today an innovative program aimed at improving the treatment of type 1 diabetes by developing novel insulin delivery products to enhance the use of insulin pumps.

From BD (Becton, Dickinson and Company) 20 Jan 2010

Liquidia Technologies completes $20M Series C financing round

Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.

20 Jan 2010

Patient enrollment for Phase 2B clinical study of Oramed Pharmaceuticals' ORMD-0801 completed

Oramed Pharmaceuticals Inc. announced today the completion of patient enrollment in the Phase 2B clinical study of its oral insulin capsule, ORMD-0801.

20 Jan 2010

Neomend receives premarket approval from FDA for ProGEL Pleural Air Leak Sealant

Neomend, Inc., an innovator in sealant and adhesion-prevention products for the surgical marketplace, announced it has received premarket approval from the U.S. Food and Drug Administration (FDA) for the company’s ProGEL™ Pleural Air Leak Sealant.

20 Jan 2010

HTDS announces possible merger with EU-based, stem-cell research company

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica BioChem want to point the shareholders back to the press release from Oct 29, 2009, where the company announced news about a possible merger with a EU based, stem-cell research company.

20 Jan 2010

Technology News and Research

Intelligent panic disorder treatment by using biofeedback analysis and web technologies

New pre-clinical data on RXi Pharmaceuticals' proprietary rxRNA compounds presented

New minimally invasive surgery for lung cancer reduces post-operative pain

New heating therapy reduces mastectomies, kills large tumors

Researchers show how gliomas can evade drugs aimed at blocking EGFR

Radiology Regional Center initiates participation in SOMO•INSIGHT Clinical Study

Ericson Manufacturing supports breast cancer research and community outreach projects

Access Pharmaceuticals provides update on its Cobalamin insulin development program

GEH, Exelon Generation agree to a landmark deal to deploy GEH’s isotope generation technology

Edwards Lifesciences' German Andersen patent for transcatheter valve technology upheld

Lumigent Technologies closes $3 million round of funding from North Bridge Venture Partners

Cook Medical presents latest advancements at ISET 2010 International Symposium on Endovascular Therapy

St. Louis Children's Hospital installs Siemens' SOMATOM Definition AS CT scanner

Dynamic mapping may help in detecting links between diseases and environmental exposures

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

Liquidia Technologies completes $20M Series C financing round

Patient enrollment for Phase 2B clinical study of Oramed Pharmaceuticals' ORMD-0801 completed

Neomend receives premarket approval from FDA for ProGEL Pleural Air Leak Sealant

HTDS announces possible merger with EU-based, stem-cell research company

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News